BioPortfolio - Chroma Therapeutics Ltd
Recent Search Terms used to find this page: Chromatherapeutics Milton | Chromatherapeutics Milton | pa@chromatherapeutics.com | chroma therapeutics USA
...
http://www.bioportfolio.com/biocorporate/20897-Chroma_Therap...
|
BioSpace - Chroma Therapeutics News, Search Jobs, Events
Chroma Therapeutics Announces Positive Phase I Efficacy Data for Novel Cancer ... Chroma Therapeutics Progresses Novel Cancer Therapy CHR-2797 Into Phase II
...
http://www.biospace.com/company_profile.aspx?CompanyId=83992...
|
BioPortfolio - Chroma Therapeutics Limited
Chroma Therapeutics Limited Patents:. US Patent No. Title. 7074578, Methods and means of histone methylation. 6890709, Assays, methods and means for ...
http://www.bioportfolio.com/biocorporate/2727-Chroma_Therape...
|
Chroma Strengthens Its Board Through the Appointment of Klaus ...
Enquiries Chroma Therapeutics Limited Ian Nicholson Chief Executive Officer +44 ... Legal. • Not-for-Profit. • Trade Policy. • U.S. State Policy News ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=...
|
BioPortfolio - Chroma Therapeutics Ltd - Profile
View the current Chroma Therapeutics Ltd Page on BioPortfolio.com .... UK Tel: ( +44) 1300 321501. USA Voicemail and Fax: (+1) 415 680 2472 ...
http://www.bioportfolio.com/biocorporate/20897-Chroma+Therap...
|
Patent News Peter Steele * & Matthew Sparrowhawk
overactive bladder (OAB) and will be co-promoted in the USA. by GlaxoSmithKline Inc (GSK). .... between Chroma Therapeutics Ltd, and the University of ...
http://www.biomedcentral.com/content/pdf/cd-563811.pdf...
|
BioPortfolio - BioPortfolio - Chroma Therapeutics Limited
BioPortfolio - Chroma Therapeutics Limited - Entry on Bioportfolio's Biocorporate ... USA Voicemail and Fax: (+1) 415 680 2472. All rights reserved.
...
http://www.bioportfolio.com/biocorporate/linkout/2727/www.ch...
|
Declaration of competing financial interests : New approaches to ...
P.W. holds stock/options in Chroma Therapeutics, PIramed and Avalon Pharmaceuticals and is a consultant for Chroma Therapeutics, PIramed, ...
http://www.nature.com/nchembio/journal/v2/n12/box/nchembio84...
|
JPMorgan – 26th Annual Healthcare Conference Part 1
based in Lexington, MA, has raised more than US $58 million. in capital and has increased its number of ... UK-based Chroma Therapeutics employs novel drug- ...
http://www.biomedcentral.com/content/pdf/cd-881155.pdf...
|
Location of U.S. Biotechnology VC Sites
For U.S. VC firms, California has the most VC sites investing in biotech, with 183, or 27 percent .... Chroma Therapeutics Ltd.; Dura Pharmaceuticals Inc.; ...
http://www.bioworld.com/img/S07402SamplePages.pdf...
|
